133 related articles for article (PubMed ID: 14563950)
21. ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines.
Weaver DA; Crawford EL; Warner KA; Elkhairi F; Khuder SA; Willey JC
Mol Cancer; 2005 May; 4(1):18. PubMed ID: 15882455
[TBL] [Abstract][Full Text] [Related]
22. Deficient gene specific repair of cisplatin-induced lesions in Xeroderma pigmentosum and Fanconi's anemia cell lines.
Zhen W; Evans MK; Haggerty CM; Bohr VA
Carcinogenesis; 1993 May; 14(5):919-24. PubMed ID: 8504485
[TBL] [Abstract][Full Text] [Related]
23. The role of Bcl-x(L) protein in nucleotide excision repair-facilitated cell protection against cisplatin-induced apoptosis.
Lomonaco SL; Xu XS; Wang G
DNA Cell Biol; 2009 Jun; 28(6):285-94. PubMed ID: 19317621
[TBL] [Abstract][Full Text] [Related]
24. Molecular determinants of treatment response in human germ cell tumors.
Mayer F; Stoop H; Scheffer GL; Scheper R; Oosterhuis JW; Looijenga LH; Bokemeyer C
Clin Cancer Res; 2003 Feb; 9(2):767-73. PubMed ID: 12576448
[TBL] [Abstract][Full Text] [Related]
25. UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency.
Tanaka K; Kamiuchi S; Ren Y; Yonemasu R; Ichikawa M; Murai H; Yoshino M; Takeuchi S; Saijo M; Nakatsu Y; Miyauchi-Hashimoto H; Horio T
Mutat Res; 2001 Jun; 477(1-2):31-40. PubMed ID: 11376684
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in the human xeroderma pigmentosum group A gene and their impact on cell survival and nucleotide excision repair.
Mellon I; Hock T; Reid R; Porter PC; States JC
DNA Repair (Amst); 2002 Jul; 1(7):531-46. PubMed ID: 12509227
[TBL] [Abstract][Full Text] [Related]
27. Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.
Koul S; McKiernan JM; Narayan G; Houldsworth J; Bacik J; Dobrzynski DL; Assaad AM; Mansukhani M; Reuter VE; Bosl GJ; Chaganti RS; Murty VV
Mol Cancer; 2004 May; 3():16. PubMed ID: 15149548
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation.
Wu X; Shell SM; Yang Z; Zou Y
Cancer Res; 2006 Mar; 66(6):2997-3005. PubMed ID: 16540648
[TBL] [Abstract][Full Text] [Related]
29. Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma.
Stevens EV; Raffeld M; Espina V; Kristensen GB; Trope' CG; Kohn EC; Davidson B
Cancer; 2005 Jun; 103(11):2313-9. PubMed ID: 15844177
[TBL] [Abstract][Full Text] [Related]
30. Binding of XPA and RPA to damaged DNA investigated by fluorescence anisotropy.
Hey T; Lipps G; Krauss G
Biochemistry; 2001 Mar; 40(9):2901-10. PubMed ID: 11258902
[TBL] [Abstract][Full Text] [Related]
31. Xeroderma Pigmentosa Group A (XPA), Nucleotide Excision Repair and Regulation by ATR in Response to Ultraviolet Irradiation.
Musich PR; Li Z; Zou Y
Adv Exp Med Biol; 2017; 996():41-54. PubMed ID: 29124689
[TBL] [Abstract][Full Text] [Related]
32. 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules.
Lai KK; Chan KT; Choi MY; Wang HK; Fung EY; Lam HY; Tan W; Tung LN; Tong DK; Sun RW; Lee NP; Law S
Tumour Biol; 2016 Feb; 37(2):2127-36. PubMed ID: 26346170
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the XPA repair gene increases resistance to ultraviolet radiation in human cells by selective repair of DNA damage.
Cleaver JE; Charles WC; McDowell ML; Sadinski WJ; Mitchell DL
Cancer Res; 1995 Dec; 55(24):6152-60. PubMed ID: 8521407
[TBL] [Abstract][Full Text] [Related]
34. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
[TBL] [Abstract][Full Text] [Related]
35. Regulation of DNA repair gene expression in human cancer cell lines.
McGurk CJ; Cummings M; Köberle B; Hartley JA; Oliver RT; Masters JR
J Cell Biochem; 2006 Apr; 97(5):1121-36. PubMed ID: 16315315
[TBL] [Abstract][Full Text] [Related]
36. Effect of XPA gene mutations on UV-induced immunostaining of PCNA in fibroblasts from xeroderma pigmentosum group A patients.
Miura M; Sasaki T
Mutat Res; 1996 Sep; 364(1):51-6. PubMed ID: 8814338
[TBL] [Abstract][Full Text] [Related]
37. Xeroderma pigmentosum complementation group A protein acts as a processivity factor.
Lambert MW; Yang L
Biochem Biophys Res Commun; 2000 May; 271(3):782-7. PubMed ID: 10814539
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin induces cytoplasmic to nuclear translocation of nucleotide excision repair factors among spiral ganglion neurons.
Guthrie OW; Li-Korotky HS; Durrant JD; Balaban C
Hear Res; 2008 May; 239(1-2):79-91. PubMed ID: 18329831
[TBL] [Abstract][Full Text] [Related]
39. EZH2 suppresses the nucleotide excision repair in nasopharyngeal carcinoma by silencing XPA gene.
Huang Y; Wang X; Niu X; Wang X; Jiang R; Xu T; Liu Y; Liang L; Ou X; Xing X; Li W; Hu C
Mol Carcinog; 2017 Feb; 56(2):447-463. PubMed ID: 27253463
[TBL] [Abstract][Full Text] [Related]
40. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
